NVIDIA (NVDA) Improvements in Gross Margins Sustainable
Get Alerts NVDA Hot Sheet
Price: $208.99 -0.81%
Rating Summary:
58 Buy, 10 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Rating Summary:
58 Buy, 10 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Join SI Premium – FREE
Nomura Securities maintained a Buy on NVIDIA (NASDAQ: NVDA) with a price target of $16.00 (from $18.00).
NVIDIA reported Q3 results that were in line on revs and better than consensus on EPS, though guidance was light. Gross margin was higher by 52.9 percent, increasing 110 bps, driven by a richer mix of Kepler shipments, noted a Nomura report.
Commenting on the results, analyst Romit Shah said "This forecast is inline with most companies that have guided 5-10 pts below seasonality. While revs are lower gross margin will remain flat, according to guidance, we believe the 28nm transition and weaker competition in GPU could help the company to sustain gross margin at these levels."
For an analyst ratings summary and ratings history on NVIDIA click here. For more ratings news on NVIDIA click here.
Shares of NVIDIA closed at $12.68 yesterday.
NVIDIA reported Q3 results that were in line on revs and better than consensus on EPS, though guidance was light. Gross margin was higher by 52.9 percent, increasing 110 bps, driven by a richer mix of Kepler shipments, noted a Nomura report.
Commenting on the results, analyst Romit Shah said "This forecast is inline with most companies that have guided 5-10 pts below seasonality. While revs are lower gross margin will remain flat, according to guidance, we believe the 28nm transition and weaker competition in GPU could help the company to sustain gross margin at these levels."
For an analyst ratings summary and ratings history on NVIDIA click here. For more ratings news on NVIDIA click here.
Shares of NVIDIA closed at $12.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Regenxbio Inc. (RGNX) PT Raised to $32 at Baird
- Forgent Power Solutions (FPS) PT Raised to $73 at TD Cowen
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
NomuraSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share